date: “2024-01-01” title: Primary sclerosing cholangitis PSC alias: Primary sclerosing cholangitis

Primary sclerosing cholangitis (PSC)

(NEJM 2016;375:1161; Clin Liver Dis 2020;15:125)

  • Diffuse inflammation of intrahepatic and extrahepatic bile ducts leading to fibrosis & stricturing of biliary system. A/w HLA-B8 and -DR3 or -DR4, frequent ⊕ autoantibodies.

  • Epi:

    • ♂ >♀ (20-50 y) ~70% Pts w/ PSC have IBD (usually UC);
    • only 1-4% w/ UC have PSC. ⊕ prognostic factors: ♂, absence of IBD, small duct PSC (Gastro 2017;152:1829).
  • Symptoms:

    • fatigue,
    • pruritus,
    • jaundice,
    • fevers,
    • RUQ pain,
    • Diarrhea → ❓ IBD: 🔎 Diagnosis: check colonoscope
    • 50% of Pts asymptomatic
  • Ddx:

  • Dx:

    • cholangiography (MRCP ± ERCP) → multifocal beaded bile duct strictures
    • exclude 2° cause
    • 一種自身抗體,即核週抗中性粒細胞胞漿抗體 (pANCA),在約 65% 的 PSC 患者中呈陽性。
    • 60% 至 80% 的 PSC 有潰瘍性結腸炎 (UC);因此,建議在診斷時進行結腸鏡檢查。
    • may miss dx if confined to small intrahepatic ducts (“small duct PSC”).
    • Liver bx if unclear: onion-skin fibrosis around bile ducts + some findings similar to PBC.
  • Treatment-Primary sclerosing cholangitis (PSC)